Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in Japan.

Treatment options for triple-class exposed (TCE) patients with multiple myeloma (MM) in Japan are limited. Retrospective observational study using the Medical Data Vision database (April 2008-April 2021). Eligible adults with MM received a new post-TCE treatment.